Logo image of USPH

U.S. PHYSICAL THERAPY INC (USPH) Stock Analyst Ratings

NYSE:USPH - New York Stock Exchange, Inc. - US90337L1089 - Common Stock

90.07  +1.52 (+1.72%)

After market: 90.07 0 (0%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to USPH. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 115.6. This target is 28.34% above the current price.
USPH was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about USPH.
In the previous month the buy percentage consensus was at a similar level.
USPH was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
USPH Historical Analyst RatingsUSPH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -97 -88 -79 -70 -61 -52 -43 -34 -25 -16 -7 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 90.07101.00116.28115.60130.20 - 12.14% 29.10% 28.34% 44.55%
USPH Current Analyst RatingUSPH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2024-12-16 JMP Securities Initiate Market Outperform
2024-12-16 B of A Securities Upgrade Neutral -> Buy
2024-12-03 JP Morgan Maintains Overweight -> Overweight
2024-11-21 Barrington Research Maintains Outperform -> Outperform
2024-11-07 Barrington Research Maintains Outperform -> Outperform
2024-10-09 Barrington Research Maintains Outperform -> Outperform
2024-10-07 B of A Securities Downgrade Buy -> Neutral
2024-09-20 Barrington Research Maintains Outperform -> Outperform
2024-08-15 Barrington Research Maintains Outperform -> Outperform
2024-05-09 Barrington Research Maintains Outperform -> Outperform
2024-03-13 JP Morgan Maintains Overweight -> Overweight
2024-03-01 Barrington Research Maintains Outperform -> Outperform
2024-01-03 Barrington Research Maintains Outperform -> Outperform
2023-11-17 JP Morgan Maintains Overweight -> Overweight
2023-11-09 Barrington Research Maintains Outperform -> Outperform
2023-09-22 JP Morgan Initiate Overweight
2023-09-19 CJS Securities Upgrade Market Perform -> Market Outperform
2023-08-14 Barrington Research Maintains Outperform -> Outperform
2023-06-30 B of A Securities Initiate Buy
2023-05-05 Barrington Research Maintains Outperform
2023-02-24 Barrington Research Maintains Outperform
2021-12-14 CJS Securities Upgrade Market Perform -> Market Outperform
2021-05-07 Barrington Research Upgrade Market Perform -> Outperform
2021-05-03 Jefferies Upgrade Hold -> Buy
2021-02-26 Barrington Research Downgrade Outperform -> Market Perform